Literature DB >> 9204745

Laparoscopic cholecystectomy for acute cholecystitis: prospective trial.

S Eldar1, E Sabo, E Nash, J Abrahamson, I Matter.   

Abstract

This prospective study determines the indications for and the optimal timing of laparoscopic cholecystectomy (LC) following the onset of acute cholecystitis. It also evaluates preoperative and operative factors associated with conversion from laparoscopic cholecystectomy to open cholecystectomy in the presence of acute cholecystitis. Having been established as the procedure of choice for elective cholelithiasis, LC is now also used for management of acute cholecystitis. Under these circumstances the procedure may be difficult and challenging. Certain favorable and unfavorable conditions may be present that influence the conversion and complication rates. Information about these conditions may be helpful for elucidating the optimal circumstances for LC or when the procedure is best avoided. We performed LC on an emergency basis as soon as the diagnosis was made on all patients presenting with acute cholecystitis from January 1994 to December 1995. All preoperative, operative, and postoperative data were collected on standardized forms. Of the 137 patients registered, 130 were eligible for the audit. Seven patients found by laparoscopic intraoperative cholangiography to have choledocholithiasis were converted for common bile duct exploration and were excluded from the study. Altogether 83 patients (72%) underwent successful LC and 37 (28%) needed conversion to open cholecystectomy. The conversion rate of acute gangrenous cholecystitis (49%) was significantly higher than that for uncomplicated acute cholecystitis (4.5%) (p < 0.00001) and for hydrops (28.5%) and empyema of the gallbladder (28.5%) (p = 0.004). The difference in conversion between the group with acute necrotizing (gangrenous) cholecystitis and the two groups with hydrops and empyema of the gallbladder was not statistically significant (p = 0.07). The complication rates of acute cholecystitis, hydrops, empyema of the gallbladder, and gangrenous cholecystitis were 9.0%, 9.5%, 14.0%, and 20.0%, respectively (p = NS). Patients with an operative delay of 96 hours or less from the onset of acute cholecystitis had a conversion rate of 23%, whereas a delay of more than 96 hours was associated with a conversion rate of 47% (p = 0.022). The complication rate was 8.5% in the laparoscopic group and 27% in the converted group (p = 0.013). Patients over 65 years of age, with a history of biliary disease, a nonpalpable gallbladder, WBC count over 13,000/cc, and acute gangrenous cholecystitis were independently associated with a high LC conversion rate; male patients, finding large bile stones, serum bilirubin over 0.8 mg/dl, and WBC count over 13,000/cc were independently associated with a high complication rate following laparoscopic surgery with or without conversion. Generally, LC can be performed safely for acute cholecystitis, with acceptably low conversion and complication rates. Different forms of cholecystitis carry various conversion and complication rates in selected cases. LC for acute cholecystitis should be performed within 96 hours of the onset of disease. Predictors of conversion and complications may be helpful when planning the laparoscopic approach to acute cholecystitis.

Entities:  

Mesh:

Year:  1997        PMID: 9204745     DOI: 10.1007/pl00012283

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  44 in total

1.  Laparoscopic cholecystectomy for acute cholecystitis: can the need for conversion and the probability of complications be predicted? A prospective study.

Authors:  A Brodsky; I Matter; E Sabo; A Cohen; J Abrahamson; S Eldar
Journal:  Surg Endosc       Date:  2000-08       Impact factor: 4.584

2.  Reasons for conversion from laparoscopic to open cholecystectomy: a 10-year review.

Authors:  Juliane Bingener-Casey; Melanie L Richards; William E Strodel; Wayne H Schwesinger; Kenneth R Sirinek
Journal:  J Gastrointest Surg       Date:  2002 Nov-Dec       Impact factor: 3.452

3.  Management of acute cholecystitis in UK hospitals: time for a change.

Authors:  I C Cameron; C Chadwick; J Phillips; A G Johnson
Journal:  Postgrad Med J       Date:  2004-05       Impact factor: 2.401

4.  Laparoscopic common bile duct exploration in patients with complicated cholecystitis: a safety and feasibility study.

Authors:  Hung-Chieh Lo; Yu-Chun Wang; Jui-Chien Huang; Cheng-Hsiung Hsu; Shih-Chi Wu; Chi-Hsun Hsieh
Journal:  World J Surg       Date:  2012-10       Impact factor: 3.352

Review 5.  Conversions during laparoscopic cholecystectomy: risk factors and effects on patient outcome.

Authors:  Benjie Tang; Alfred Cuschieri
Journal:  J Gastrointest Surg       Date:  2006 Jul-Aug       Impact factor: 3.452

6.  Urgent laparoscopic cholecystectomy in the management of acute cholecystitis: timing does not influence conversion rate.

Authors:  Y-C Wang; H-R Yang; P-K Chung; L-B Jeng; R-J Chen
Journal:  Surg Endosc       Date:  2006-03-16       Impact factor: 4.584

7.  Laparoscopic cholecystectomy for acute cholecystitis: safe implementation of successful strategies to reduce conversion rates.

Authors:  Shiong-Wen Low; Shridhar Ganpathi Iyer; Stephen K-Y Chang; Kenneth S W Mak; Victor Tswen Wen Lee; Krishnakumar Madhavan
Journal:  Surg Endosc       Date:  2009-03-05       Impact factor: 4.584

8.  Single-incision vs three-incision laparoscopic cholecystectomy for complicated and uncomplicated acute cholecystitis.

Authors:  Shu-Hung Chuang; Pai-Hsi Chen; Chih-Ming Chang; Chih-Sheng Lin
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

9.  Current status of surgical management of acute cholecystitis in the United States.

Authors:  Nicholas Csikesz; Rocco Ricciardi; Jennifer F Tseng; Shimul A Shah
Journal:  World J Surg       Date:  2008-10       Impact factor: 3.352

10.  Delayed laparoscopic subtotal cholecystectomy in acute cholecystitis with severe fibrotic adhesions.

Authors:  Atsushi Horiuchi; Yuji Watanabe; Takashi Doi; Kouichi Sato; Shungo Yukumi; Motohira Yoshida; Yuji Yamamoto; Hiroki Sugishita; Kanji Kawachi
Journal:  Surg Endosc       Date:  2008-04-04       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.